Palliative Care for Non-Malignant Diseases (COMPASS Trial)

Stopped early · Not applicable

Conditions studied: Liver Diseases, Liver Cirrhosis, NASH (Non-Alcoholic Steatohepatitis)

In brief

The purpose of this study is to evaluate, through a randomized controlled trial, the impact of integrated comprehensive palliative care services on time to first hospital readmission and other hospital utilization outcomes, quality of life, and patient/caregiver outcomes. The intervention includes comprehensive, standardized palliative care services for adult hepatology cirrhosis patients for which prognosis is poor.

Key facts

Study ID

NCT03022630

Run by

Vanderbilt University Medical Center

People needed

63

Starts

2017-02-06

Expected to finish

2018-06-21

Last updated by the study team

2019-11-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Inpatient at Vanderbilt University Medical Center with advanced cirrhotic liver disease, whose treating hepatologist indicates a 'No' response to the question, "Would you be surprised if this patient died within 1 year?"

You may not qualify if…

• Age < 18 years
• Receipt of liver transplant at the time of potential enrollment
• Inability to give written informed consent (patient or surrogate decision-maker)
• Inability to respond to questions in English
• Treating hepatologist denies permission to enroll
• Receiving hepatology care at non-Vanderbilt sites (to ensure appropriate follow-up)

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.